Nanobody engineering for SARS-CoV-2 neutralization and detection
L. Hannula, S. Kuivanen, J. Lasham, R. Kant, L. Kareinen, M. Bogacheva, T. Strandin, T. Sironen, V. Sharma, P. Saviranta, A. Kipar, O. Vapalahti, J. T. Huiskonen, I. Rissanen
This study engineers nanobodies to neutralize SARS-CoV-2 variants and develop a detection assay, showing high potency against some variants but limitations against others.
bioRxiv · Sep 14, 2022Microbiology